GLIDAPAFLOZIN TRIO 2 FORTE 

Dapagliflozin (10mg) , Glimepiride (2mg) & Metformin Hydrochloride (1000mg) ( extended Release )

GLIDAPAFLOZIN TRIO 2 FORTE is a combination medication used for managing type 2 diabetes mellitus. This tablet integrates three key antidiabetic agents—Dapagliflozin, Glimepiride, and Metformin Hydrochloride—into one formulation, offering a comprehensive approach to blood sugar control.

Active Ingredients

Dapagliflozin (10mg):

Class: SGLT2 Inhibitor
Mechanism: Dapagliflozin inhibits the sodium-glucose co-transporter 2 in the kidney, reducing glucose reabsorption and promoting its excretion through urine.
Benefits: Effective in lowering blood sugar levels, it may also support weight loss and has potential cardiovascular benefits.
Glimepiride (2mg):

Class: Sulfonylurea
Mechanism: Glimepiride enhances insulin secretion from the pancreas, which helps in lowering blood glucose levels.
Benefits: It effectively manages blood sugar by increasing insulin production, contributing to better glycemic control.
Metformin Hydrochloride (1000mg, Extended Release):

Class: Biguanide
Mechanism: Metformin decreases glucose production by the liver and improves insulin sensitivity in the body’s tissues.
Benefits: It stabilizes blood sugar levels, reduces the risk of hypoglycemia, and promotes weight stability.
Uses

Type 2 Diabetes Management: GLIDAPAFLOZIN TRIO 2 FORTE is used to improve blood sugar control in patients with type 2 diabetes, especially when diet and exercise alone are inadequate.
Combination Therapy: By combining these three agents, the medication offers a multifaceted approach to diabetes management, addressing different mechanisms involved in blood glucose regulation.
Dosage and Administration

Typically, one tablet is taken daily with food to minimize gastrointestinal side effects.
Side Effects

Common side effects may include nausea, diarrhea, and urinary tract infections. Rare but serious effects could involve hypoglycemia, lactic acidosis, and renal issues.
Conclusion

GLIDAPAFLOZIN TRIO 2 FORTE provides an effective and convenient option for managing type 2 diabetes, combining the benefits of three potent antidiabetic agents in a single tablet. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. 

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488  

BUY NOW